BeiGene, Ltd. Uncategorized Contracts & Agreements

17 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
BeiGene, Ltd.
Biotechnology
2025
Offer Letter
BeiGene, Ltd.
Biotechnology
2024
Description of the Registrant
BeiGene, Ltd.
Biotechnology
NY
2024
Offer Letter, dated June 10, 2022, by and between the Registrant and Chan Lee
BeiGene, Ltd.
Biotechnology
2023
Description of
BeiGene, Ltd.
Biotechnology
NY
2023
Description of BeiGene, Ltd.'s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
BeiGene, Ltd.
Biotechnology
NY
2022
U.S. Letter Agreement, dated as of November 30, 2021, by and among the Company and China International Capital Corporation Limited, Goldman Sachs Gao Hua Securities Co. Ltd.,...
BeiGene, Ltd.
Biotechnology
NY
2021
Offer Letter, dated May 29, 2020, by and between the Registrant and Julia Wang
BeiGene, Ltd.
Biotechnology
2021
Description of BeiGene, Ltd.'s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
BeiGene, Ltd.
Biotechnology
NY
2021
Description of BeiGene, Ltd.'s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
BeiGene, Ltd.
Biotechnology
NY
2020
Amended and Restated BeiGene, Ltd. 2018 Inducement Equity Plan
BeiGene, Ltd.
Biotechnology
2018
BeiGene, Ltd. 2018 Inducement Equity Plan
BeiGene, Ltd.
Biotechnology
2018
FORM BeiGene, Ltd.
BeiGene, Ltd.
Biotechnology
NY
2017
BeiGene, Ltd.
BeiGene, Ltd.
Biotechnology
NY
2016
SECOND AMENDMENT AGREEMENT
BeiGene, Ltd.
Biotechnology
2015
BEIGENE, LTD. NUMBER INCORPORATED IN THE CAYMAN ISLANDS UNDER THE COMPANIES LAW ORDINARY (AS AMENDED OR REVISED FROM TIME TO TIME) SHARES [certificate no.] [no. of shares]
BeiGene, Ltd.
Biotechnology
2015
BEIGENE, LTD 2011 OPTION PLAN (the Plan)
BeiGene, Ltd.
Biotechnology
2015